FDA Guidance Document Development Process 

By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) is seeking public comment on a draft “Report and Plan on Best Practices for Guidance.” Guidance documents, rather…

Read More

Increased FDA Scrutiny of Eye Care Category 

By Alvin J. Lorman, AAHP Counsel  The Food and Drug Administration (FDA) last week continued its heightened surveillance on ophthalmic drug products sold without FDA approval or without complying with…

Read More

What’s In a Name?

By Al Lorman, AAHP Counsel FDA’s issuance of its new guidance on homeopath drugs in December, 2022 has caused concern in some quarters because of the language used by the…

Read More